Literature DB >> 32945735

Efficacy of Daily Intake of Dried Cranberry 500 mg in Women with Overactive Bladder: A Randomized, Double-Blind, Placebo Controlled Study.

Ahra Cho1, Andrew Eidelberg1, Daniel J Butler2, David Danko2,3, Ebrahim Afshinnekoo2,4,5, Christopher E Mason2,4,5,6, Bilal Chughtai1.   

Abstract

PURPOSE: We sought to determine the efficacy of dried cranberry on reducing symptoms of overactive bladder in women.
MATERIALS AND METHODS: Eligible women aged 18 or older with overactive bladder were randomized to either daily dried cranberry powder (500 mg) or placebo (500 mg) and followed for 24 weeks. Efficacy was measured by 3-day voiding diaries and Overactive Bladder Questionnaire Short Form, Patient Perception of Bladder Condition, Sexual Quality of Life-Female and Pelvic Floor Distress Inventory surveys. Statistical analyses were performed by BIOFORTIS using SAS® software version 9.4.
RESULTS: Of the 98 women who were randomized 77 completed all the visits and 60 were included in the per protocol analysis. Compared to placebo using per protocol analysis the cranberry group showed a significant reduction of daily micturitions (-1.91, 95% CI -3.74--0.88, p=0.0406), urgency episodes (-2.81, 95% CI -4.82--0.80, p=0.0069), and Patient Perception of Bladder Condition scores (-0.66, 95% CI -1.23-0.08, p=0.0258) at 24 weeks of followup. Mean volume per micturition, nocturia and the remaining survey outcomes did not differ significantly between the groups (p >0.05).
CONCLUSIONS: Daily intake of dried cranberry powder reduced daily micturition by 16.4%, urgency episodes by 57.3% and patient perception of bladder condition by 39.7%. However, an intent-to-treat analysis showed no statistically significant difference between the groups for these measurements (p >0.05). Future larger studies with longer followup periods are needed to further determine the long-term effect of cranberry on overactive bladder.

Entities:  

Keywords:  Vaccinium macrocarpon; urinary bladder, overactive; urination; urination disorders, perception

Mesh:

Year:  2020        PMID: 32945735      PMCID: PMC8299659          DOI: 10.1097/JU.0000000000001384

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  25 in total

1.  Role of complimentary therapy for male LUTS.

Authors:  Philippa J Cheetham
Journal:  Curr Urol Rep       Date:  2013-12       Impact factor: 3.092

Review 2.  Disease burden of overactive bladder: quality-of-life data assessed using ICI-recommended instruments.

Authors:  Ramandeep Basra; Con Kelleher
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

3.  Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline.

Authors:  E Ann Gormley; Deborah J Lightner; Kathryn L Burgio; Toby C Chai; J Quentin Clemens; Daniel J Culkin; Anurag Kumar Das; Harris Emilio Foster; Harriette Miles Scarpero; Christopher D Tessier; Sandip Prasan Vasavada
Journal:  J Urol       Date:  2012-10-24       Impact factor: 7.450

4.  A phase III, randomized, double-blind, parallel-group, placebo-controlled, multicentre study to assess the efficacy and safety of the β₃ adrenoceptor agonist, mirabegron, in patients with symptoms of overactive bladder.

Authors:  Sender Herschorn; Jack Barkin; David Castro-Diaz; Jeffrey M Frankel; Montserrat Espuna-Pons; Angelo E Gousse; Matthias Stölzel; Nancy Martin; Adrie Gunther; Philip Van Kerrebroeck
Journal:  Urology       Date:  2013-06-13       Impact factor: 2.649

5.  Vibegron (RVT-901/MK-4618/KRP-114V) Administered Once Daily as Monotherapy or Concomitantly with Tolterodine in Patients with an Overactive Bladder: A Multicenter, Phase IIb, Randomized, Double-blind, Controlled Trial.

Authors:  Henry D Mitcheson; Suvajit Samanta; Karen Muldowney; Cathy A Pinto; Beatriz de A Rocha; Stuart Green; Nathan Bennett; Paul N Mudd; Tara L Frenkl
Journal:  Eur Urol       Date:  2018-10-25       Impact factor: 20.096

6.  Use of herbal supplements for overactive bladder.

Authors:  Bilal Chughtai; Elizabeth Kavaler; Richard Lee; Alexis Te; Steven A Kaplan; Franklin Lowe
Journal:  Rev Urol       Date:  2013

7.  Association of age, race, and obstetric history with urinary symptoms among women in the Nurses' Health Study.

Authors:  Francine Grodstein; Ruth Fretts; Karen Lifford; Neil Resnick; Gary Curhan
Journal:  Am J Obstet Gynecol       Date:  2003-08       Impact factor: 8.661

8.  Randomized, double-blind placebo controlled trial of the once daily antimuscarinic agent solifenacin succinate in patients with overactive bladder.

Authors:  L Cardozo; M Lisec; R Millard; O van Vierssen Trip; I Kuzmin; T E Drogendijk; M Huang; A M Ridder
Journal:  J Urol       Date:  2004-11       Impact factor: 7.450

Review 9.  Pharmacologic management of overactive bladder.

Authors:  Sum Lam; Olga Hilas
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

Review 10.  Cranberries and their bioactive constituents in human health.

Authors:  Jeffrey B Blumberg; Terri A Camesano; Aedin Cassidy; Penny Kris-Etherton; Amy Howell; Claudine Manach; Luisa M Ostertag; Helmut Sies; Ann Skulas-Ray; Joseph A Vita
Journal:  Adv Nutr       Date:  2013-11-06       Impact factor: 8.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.